Wuxi Venture Capital Group logo

Wuxi Venture Capital Group

Asia, Anhui, China, Wuxi

Description

Wuxi Venture Capital Group is an equity and venture capital institution.

Investor Profile

Wuxi Venture Capital Group has backed more than 10 startups, with 7 new investments in the last 12 months alone. The firm has led 2 rounds, about 20% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C, Series D rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Manufacturing, Robotics.
  • Led 1 rounds in the past year.

Stage Focus

  • Series A (60%)
  • Series C (10%)
  • Series D (10%)
  • Seed (10%)
  • Series E (10%)

Country Focus

  • China (80%)
  • United States (20%)

Industry Focus

  • Biotechnology
  • Manufacturing
  • Robotics
  • Therapeutics
  • Biopharma
  • Neuroscience
  • Life Science
  • Pharmaceutical
  • Medical
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Wuxi Venture Capital Group frequently co-invest with?

Johnson & Johnson Innovation – JJDC
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Connecticut Innovations
North America, Connecticut, United States, Rocky Hill
Co-Investments: 1
Orient Hontai Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
KTB Network
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
Trinity Innovation Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 2
WI Harper Group
North America, California, United States, San Francisco
Co-Investments: 1
Panacea Venture
Asia, Shanghai, China, Shanghai
Co-Investments: 1
CDIB Capital
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1

What are some of recent deals done by Wuxi Venture Capital Group?

Galaxea AI

Suzhou, Jiangsu, China

Galaxea AI is an intelligent robot technology company that specializes in the development of humanoid robots with embodied intelligence.

Intelligent SystemsManufacturingRobotics
Series AJul 9, 2025
Amount Raised: $13,927,771
Zhibo Quan

Wuxi, Anhui, China

Zhibo Quan is the Robot joint developer company that offers robot joint research and development, production, testing and assembly services.

Product ResearchRoboticsTest and Measurement
Series AJun 16, 2025
Meijie Optoelectronics

Shanghai, Shanghai, China

Meijie Optoelectronics is a hi-tech manufacturing firm that makes testing equipment for semiconductors.

Information TechnologyManufacturingSemiconductor
Series AMar 21, 2025
Amount Raised: $27,589,061
Eyou Robot

Wuxi, Anhui, China

Eyou Robot develops and produces humanoid drive systems, including joint modules for various robot applications.

Industrial EngineeringManufacturingRobotics
Series AMar 6, 2025
Amount Raised: $6,900,168

LinkedCare is a consumer medical digital service platform that provides operation and management solutions for consumer medical enterprises.

Health Care
Series EJan 8, 2025
Picea Motion

Shenzhen, Guangdong, China

Picea Motion is a precision harmonic drive company that specializes in the development and production of harmonic speed reducers.

Advanced MaterialsIndustrial AutomationIndustrial Manufacturing
Series AJan 2, 2025
Amount Raised: $41,098,142
Galaxea AI

Suzhou, Jiangsu, China

Galaxea AI is an intelligent robot technology company that specializes in the development of humanoid robots with embodied intelligence.

Intelligent SystemsManufacturingRobotics
SeedNov 4, 2024
Amount Raised: $28,173,776
BioCityPharma

Shanghai, Shanghai, China

BioCityPharma is a clinical-stage biopharmaceutical firm.

Series AAug 1, 2024
XWPharma

Redwood City, California, United States

XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses.

BiopharmaBiotechnologyNeuroscience
Series CSep 17, 2020
Amount Raised: $40,000,000
Simcha Therapeutics

New Haven, Connecticut, United States

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

BiotechnologyLife SciencePharmaceuticalTherapeutics
Series AJun 25, 2020
Amount Raised: $25,000,000